Weaning of immunosuppression in living donor liver transplant recipients

Transplantation

Volumn 72, Issue 3, 2001, Pages 449-454

  Takatsuki, Mitsuhisa ^a,b   Uemoto, Shinji ^a   Inomata, Yukihiro ^a   Egawa, Hiroto ^a   Kiuchi, Tetsuya ^a   Fujita, Shiro ^a   Hayashi, Michihiro ^a   Kanematsu, Takashi ^b   Tanaka, Koichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

ADOLESCENT; ARTICLE; BOLUS INJECTION; CHILD; DISEASE COURSE; DOSE RESPONSE; DRUG WITHDRAWAL; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; LIVER TRANSPLANTATION; LIVING DONOR; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL; TREATMENT OUTCOME; WEANING;

EID: 0035881424     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200108150-00016     Document Type: Article

References (24)

1. Weaning of immunosuppression in long-term liver transplant recipients
2. Weaning of immunosuppression in liver transplant recipients
3. Defining the outcome of immunosuppression withdrawal after liver transplantation
4. The evolution of immunosuppression with FK 506 in pediatric living-related liver transplantation
5. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model
6. Apoptosis within spontaneously accepted mouse liver allografts
7. A role for CD95 ligand in preventing graft rejection
8. Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
9. Role of HLA compatibility in pediatric liver transplantation
10. Influence of human leukocyte antigen matching on liver allograft survival and rejection; the dualistic effect
11. HLA compatibility and organ transplant survival
12. Right robe graft in living donor liver transplantation
13. Growth and quality of life after living-related liver transplantation in children
14. Cell migration, chimerism, and graft acceptance
15. Antigen localization and migration in immunity and tolerance
16. Comparison of T cell responses in patients with a long-term surviving renal allograft versus a long-term surviving liver allograft
17. Donor-specific hyporeactivity after liver transplantation
18. Temporary withdrawal of immunosuppression for life-threatening infections after liver transplantation
19. Long-term allograft acceptance in a patient with posttransplant lymphoproliferative disorder
20. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
21. Tolerance to rat liver allografts. III. Donor cell migration and tolerance-associated cytokine production in peripheral lymphoid tissues
22. Timing, significance, and prognosis of late acute liver allograft rejection
23. Incidence of late acute rejection and progression to chronic rejection in pediatric liver recipients